Matija Tomsic Selected Research

Matija Tomsic Research Topics

10	Rheumatoid Arthritis 01/2020 - 09/2008
3	Axial Spondyloarthritis 11/2022 - 01/2020
3	Psoriatic Arthritis 01/2022 - 01/2020
3	Ankylosing Spondylitis 01/2020 - 02/2008
2	Arthritis (Polyarthritis) 11/2022 - 10/2009
2	Tuberculosis (Tuberculoses) 01/2020 - 11/2012
2	Latent Tuberculosis 01/2020 - 11/2012
2	Inflammation (Inflammations) 04/2016 - 01/2015
2	Fatigue 05/2015 - 06/2011
2	Atherosclerosis 11/2013 - 01/2006
2	Infections 11/2012 - 02/2008
2	Pain (Aches) 06/2011 - 01/2009
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Giant Cell Arteritis (Horton Disease) 04/2016
1	Systemic Scleroderma (Systemic Sclerosis) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2013
1	Rheumatic Diseases (Rheumatism) 03/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2012
1	Mental Fatigue 06/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2009
1	Drug-Related Side Effects and Adverse Reactions 10/2009
1	Osteitis 02/2008

5	Antirheumatic Agents (DMARD)IBA 11/2022 - 09/2008
5	Rituximab (Mabthera)FDA Link 01/2017 - 09/2011
4	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 09/2011
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2016 - 11/2013
3	Leflunomide (Arava)FDA LinkGeneric 03/2012 - 09/2008
2	secukinumabIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2016 - 01/2015
2	Prostaglandins AIBA 05/2015 - 06/2011
2	AutoantibodiesIBA 01/2012 - 09/2011
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 10/2009 - 09/2008
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 04/2016
1	GlucocorticoidsIBA 04/2016
1	HaptoglobinsIBA 04/2016
1	Fibrinogen (Factor I)FDA Link 04/2016
1	N-phthaloylglutamic acidIBA 05/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 03/2012
1	AntibodiesIBA 01/2012
1	teriflunomideIBA 10/2009
1	Cytochrome P-450 CYP2C19IBA 10/2009
1	dopastinIBA 10/2009
1	NitrogenIBA 01/2009
1	Oxygen (Dioxygen)IBA 01/2009
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2006